Broncus Holding Corporation

Equities

2216

KYG1609T1022

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. Other stock markets 04:08:35 2024-04-19 am EDT			5-day change	1st Jan Change
0.54 ^HKD	0.00%		-10.00%	-31.65%

Mar. 28	Broncus Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 01	Broncus Holding Corporation Announces Resignation of Zhenjun Zi as Non-Executive Director	CI

Unicorn Holding Partners LP announced that it expects to receive $3 million in funding from Broncus Holding Corporation

December 05, 2021

Unicorn Holding Partners LP announced a subscription agreement of limited partnership interest of not more than $3,000,000 on December 6, 2021. The transaction will include participation from Broncus Holding Corporation for 1.11% stake.

Latest news about Broncus Holding Corporation

Broncus Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Broncus Holding Corporation Announces Resignation of Zhenjun Zi as Non-Executive Director	Mar. 01	CI
Broncus Holding Corporation Announces Passing Away of Joseph Wan Yee Lau, an Independent Non-Executive Director and Member of the Audit Committee and Nomination Committee	Feb. 07	CI
Broncus Arm Terminates License Agreement With NoahTron Intelligence	Nov. 27	MT
Broncus Unit to Purchase Medical Device Maker	Nov. 23	MT
Broncus Acquires Fibernova for $2.7 Million	23-09-11	MT
Broncus Holding Corporation entered into share purchase agreement to acquire Fibernova Holding Corporation from from Zhao and others for $2.7 million.	23-09-07	CI
Broncus Holding Corporation Announces Chief Executive Officer Changes, Effective on September 1, 2023	23-08-29	CI
Broncus Holding Corporation Announces Re-Designation of Guowei Zhan from an Executive Director to Non-Executive Director, Effective September 1, 2023	23-08-29	CI
Broncus Holding Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Broncus Holding Corporation Completes the First Case of Registered Clinical Trials of Its Targeted Lung Denervation Radiofrequency Ablation System	23-07-10	CI
Broncus Completes First Case of Clinical Trials for COPD Treatment	23-07-09	MT
Broncus Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Broncus Flags Nearly $12 Million Exposure to Silicon Valley Bank	23-03-13	MT
Chinese shares jump on recovery optimism, Fed pause bets	23-03-12	RE
Over a dozen Chinese-based firms say they have minimal exposure to SVB	23-03-12	RE
Six Hong Kong-listed firms say their deposits at SVB are immaterial	23-03-12	RE
TechStar Acquisition Launches Hong Kong IPO	22-12-20	MT
Broncus Holding Corporation Announces Zhejiang Medical Products Administration Approves Disposable Nebulizing Micro-Catheter for Endoscope for Marketing in China	22-10-31	CI
China Approves Market Launch of Broncus Nebulizing Micro-catheter	22-10-31	MT
Certain Ordinary Shares of Broncus Holding Corporation are subject to a Lock-Up Agreement Ending on 25-SEP-2022.	22-09-24	CI
Broncus Holding Corporation(SEHK:2216) dropped from S&P Global BMI Index	22-09-19	CI
Healium Medical Enters into Strategic Cooperation Agreement with Broncus Holding Corporation	22-09-13	CI
Broncus Holding Posts Lower H1 Loss	22-08-30	MT
Broncus Holding Corporation Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-30	CI

Chart Broncus Holding Corporation

Duration

Period

More charts

Company Profile

Broncus Holding Corp is a China-based investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Broncus Holding Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.069 USD

Average target price

0.137 USD

Spread / Average Target

+98.68%

Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Imaging Systems

	1st Jan change	Capi.
BRONCUS HOLDING CORPORATION	-31.65%	36.35M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-10.31%	13.99B
IRAY TECHNOLOGY COMPANY LIMITED	-40.33%	2.73B
SONOSCAPE MEDICAL CORP.	-20.66%	2.23B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-15.69%	1.4B
NANO-X IMAGING LTD.	+42.39%	524M
GUERBET	+68.46%	445M
DETECTION TECHNOLOGY OYJ	-2.19%	216M
VIEWORKS CO., LTD.	+1.11%	182M
INTROMEDIC CO., LTD.	-.--%	168M

Medical Imaging Systems